1987
DOI: 10.1128/aac.31.6.844
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition by ganciclovir of cell growth and DNA synthesis of cells biochemically transformed with herpesvirus genetic information

Abstract: The ability of LM cells, thymidine kinase-deficient LM cells (LMTK-), and LMTK-cells transformed to the LMTK+ phenotype by herpes simplex virus type 1 genetic information (LH7 cells) to anabolize the acyclovir congener ganciclovir was examined. About 50-fold more ganciclovir triphosphate was produced by LH7 cells than by either LM or LMTK-cells. Growth inhibition studies indicated that 180 and 120 ,uM ganciclovir were required to achieve 50% growth inhibition of LM and LMTK-cells, respectively; only 0.07 ,uM g… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
26
0

Year Published

1992
1992
2014
2014

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 84 publications
(26 citation statements)
references
References 26 publications
0
26
0
Order By: Relevance
“…Incorporation of these metabolites into elongating DNA blocks elongation leading to cell death. [2][3][4] The HSV1tk/GCV system has proved efficient for inducing the regression of transplanted tumors in various animal models, 5 as well as of carcinogen-induced tumors. 6 Based on these favourable results, several clinical gene therapy trials are in progress aimed at assessing safety and efficacy of this treatment for treating malignancies, and preliminary results have now been reported.…”
Section: Abstract: Nucleoside Analogs; Cancer; Fusion Proteinsmentioning
confidence: 99%
“…Incorporation of these metabolites into elongating DNA blocks elongation leading to cell death. [2][3][4] The HSV1tk/GCV system has proved efficient for inducing the regression of transplanted tumors in various animal models, 5 as well as of carcinogen-induced tumors. 6 Based on these favourable results, several clinical gene therapy trials are in progress aimed at assessing safety and efficacy of this treatment for treating malignancies, and preliminary results have now been reported.…”
Section: Abstract: Nucleoside Analogs; Cancer; Fusion Proteinsmentioning
confidence: 99%
“…1,2 In this approach, the suicide gene encodes an enzyme (ie herpes simplex thymidine kinase (HSVtk) or cytosine deaminase) that is capable of converting a systemically delivered pro-drug (ie ganciclovir, 5-fluorocytosine) into a toxic metabolite that induces cell death. [3][4][5][6][7] A variety of vectors has been used to deliver suicide genes; however, the use of recombinant adenoviruses has probably stimulated the most research interest in the past decade. This is due to the ability of adenoviruses to infect a wide variety of dividing and non-dividing cells, their large packaging capacity (approximately 7.5 kb), and their ability to be propagated to produce high titers for use in clinical trials.…”
Section: Introductionmentioning
confidence: 99%
“…Cellular enzymes then phosphorylate the prodrug to the active nucleoside triphosphate. The viral DNA polymerase incorporates the metabolites preferentially into the elongating viral DNA, resulting in DNA-chain termination [4,5]. Recently, the herpesviral TK, such as those of HSV (herpes simplex virus), VZV (Varicella Zoster virus), equine herpes virus 4 and EBV (Epstein-Barr virus) [6][7][8][9] also have been found to be useful suicide genes in gene therapy.…”
Section: Introductionmentioning
confidence: 99%